Sonia M. Davis

21.5k total citations · 6 hit papers
103 papers, 15.2k citations indexed

About

Sonia M. Davis is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Sonia M. Davis has authored 103 papers receiving a total of 15.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Psychiatry and Mental health, 15 papers in Physiology and 14 papers in Pharmacology. Recurrent topics in Sonia M. Davis's work include Schizophrenia research and treatment (40 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers) and Bipolar Disorder and Treatment (14 papers). Sonia M. Davis is often cited by papers focused on Schizophrenia research and treatment (40 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers) and Bipolar Disorder and Treatment (14 papers). Sonia M. Davis collaborates with scholars based in United States, United Kingdom and Canada. Sonia M. Davis's co-authors include Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy, John Hsiao, Robert A. Rosenheck, Marvin S. Swartz, Richard S.E. Keefe, Diana O. Perkins, Barry D. Lebowitz and C.E. Davis and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Sonia M. Davis

101 papers receiving 14.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

2005 4.2k citations Jeffrey A. Lieberman, T. Scott Stroup et al. New England Journal of Medicine profile →
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

2005 897 citations Joseph P. McEvoy, Jonathan M. Meyer et al. Schizophrenia Research profile →
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

2006 760 citations Sonia M. Davis, John Hsiao et al. New England Journal of Medicine profile →
Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment

2006 557 citations Joseph P. McEvoy, Jeffrey A. Lieberman et al. American Journal of Psychiatry profile →
Gender Differences in Treatment Response to Sertraline Versus Imipramine in Chronic Depression

2000 509 citations Susan G. Kornstein, Sonia M. Davis et al. American Journal of Psychiatry profile →
Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort

2017 397 citations Sonia M. Davis, Sonia Thomas et al. profile →

Peers

Countries citing papers authored by Sonia M. Davis

Since Specialization

Citations

This map shows the geographic impact of Sonia M. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonia M. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonia M. Davis more than expected).

Fields of papers citing papers by Sonia M. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonia M. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonia M. Davis. The network helps show where Sonia M. Davis may publish in the future.

Co-authorship network of co-authors of Sonia M. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Sonia M. Davis. A scholar is included among the top collaborators of Sonia M. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonia M. Davis. Sonia M. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of dispositional optimism with Life’s Simple 7’s Cardiovascular Health Index: results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Sociocultural Ancillary Study (SCAS) 2018 ·BMJ Open ·Rosalba Hernández, Héctor M. González, Wassim Tarraf, Judith T. Moskowitz, Mercedes R. Carnethon, Linda C. Gallo, Frank J. Penedo, Carmen R. Isasi, John Ruiz, William Argüelles, Christina Buelna, Sonia M. Davis, Franklyn Gonzalez, Jessica L. McCurley, Dong‐Hong Wu, Martha L. Daviglus	20
2	Stress and sleep: Results from the Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary Study 2017 ·SSM - Population Health ·Carmela Alcántara, Sanjay R. Patel, Mercedes R. Carnethon, Sheila F. Castañeda, Carmen R. Isasi, Sonia M. Davis, Alberto R. Ramos, Elva M. Arredondo, Susan Redline, Phyllis C. Zee, Linda C. Gallo	92
3	Spirometry Reference Equations from the HCHS/SOL (Hispanic Community Health Study/Study of Latinos) 2017 ·American Journal of Respiratory and Critical Care Medicine ·Lisa M. LaVange, Sonia M. Davis, John Hankinson, Paul Enright, (unknown), R. Graham Barr, Sonia Thomas, Ravi Kalhan, Hector Lemus, Ai Ni, Lewis J. Smith, Gregory A. Talavera	21
4	Pulmonary Disease and Age at Immigration among Hispanics. Results from the Hispanic Community Health Study/Study of Latinos 2015 ·American Journal of Respiratory and Critical Care Medicine ·R. Graham Barr, Larissa Avilés‐Santa, Sonia M. Davis, (unknown), Franklyn Gonzalez, Ashley G. Henderson, Robert C. Kaplan, Lisa M. LaVange, Kiang Liu, José S. Loredo, Eliana S. Mendes, Ai Ni, Andrew L. Ries, Matthias Salathé, Lewis J. Smith	48
5	The association between weight change and symptom reduction in the CATIE schizophrenia trial 2011 ·Schizophrenia Research ·Eric D. A. Hermes, Henry A. Nasrallah, Vicki G. Davis, Jonathan M. Meyer, Joseph P. McEvoy, Donald Goff, Sonia M. Davis, T. Scott Stroup, Marvin S. Swartz, Jeffrey A. Lieberman, Robert A. Rosenheck	64
6	Impact of Second-Generation Antipsychotics and Perphenazine on Depressive Symptoms in a Randomized Trial of Treatment for Chronic Schizophrenia 2010 ·The Journal of Clinical Psychiatry ·Donald Addington, Somaia Mohamed, Robert A. Rosenheck, Sonia M. Davis, T. Scott Stroup, Joseph P. McEvoy, Marvin S. Swartz, Jeffrey A. Lieberman	22
7	Employment Outcomes in a Randomized Trial of Second-Generation Antipsychotics and Perphenazine in the Treatment of Individuals with Schizophrenia 2008 ·The Journal of Behavioral Health Services & Research ·Sandra G. Resnick, Robert A. Rosenheck, José M. Cañive, (unknown), T. Scott Stroup, Joseph P. McEvoy, Sonia M. Davis, Richard S.E. Keefe, Marvin S. Swartz, Jeffrey A. Lieberman	21
8	Special Section on Implications of CATIE: What CATIE Found: Results From the Schizophrenia Trial 2008 ·Psychiatric Services ·Marvin S. Swartz, T. Scott Stroup, Joseph P. McEvoy, Sonia M. Davis, Robert A. Rosenheck, Richard S.E. Keefe, John Hsiao, Jeffrey A. Lieberman	97
9	The impact of obesity on health care costs among persons with schizophrenia 2008 ·General Hospital Psychiatry ·Lydia Chwastiak, Robert A. Rosenheck, Joseph P. McEvoy, T. Scott Stroup, Marvin S. Swartz, Sonia M. Davis, Jeffrey A. Lieberman	35
10	Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1 2008 ·Schizophrenia Research ·Jonathan M. Meyer, Vicki G. Davis, Donald Goff, Joseph P. McEvoy, Henry A. Nasrallah, Sonia M. Davis, Robert A. Rosenheck, Gail L. Daumit, John Hsiao, Marvin S. Swartz, T. Scott Stroup, Jeffrey A. Lieberman	210
11	Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic 2006 ·American Journal of Psychiatry ·T. Scott Stroup, Jeffrey A. Lieberman, Joseph P. McEvoy, Marvin S. Swartz, Sonia M. Davis, Robert A. Rosenheck, Diana O. Perkins, Richard S.E. Keefe, C.E. Davis, Joanne B. Severe, John Hsiao, (unknown)	212
12	Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial 2006 ·Neuropsychopharmacology ·Richard S.E. Keefe, Robert M. Bilder, Philip D. Harvey, Sonia M. Davis, Barton W. Palmer, James M. Gold, Herbert Y. Meltzer, Michael F. Green, Del D. Miller, José M. Cañive, Lawrence Adler, Theo C. Manschreck, Marvin S. Swartz, Robert A. Rosenheck, Diana O. Perkins, Trina M. Walker, T. Scott Stroup, Joseph P. McEvoy, Jeffrey A. Lieberman	372
13	Vagus Nerve Stimulation for Treatment-Resistant\nDepression: A Randomized, Controlled Acute\nPhase Trial 2005 ·Insecta mundi ·A. John Rush, Lauren B. Marangell, Harold A. Sackeïm, Mark S. George, Stephen K. Brannan, Sonia M. Davis, Robert H. Howland, Mitchel A. Kling, Barry R. Rittberg, W. J. Burke, Mark Hyman Rapaport, John Zajecka, Andrew A. Nierenberg, Mustafa M. Husain, David Ginsberg, R.G. Cooke	416
14	Vagus Nerve Stimulation for Treatment-Resistant Depression: A Randomized, Controlled Acute Phase Trial 2005 ·Biological Psychiatry ·A. John Rush, Lauren B. Marangell, Harold A. Sackeïm, Mark S. George, Stephen K. Brannan, Sonia M. Davis, Robert H. Howland, Mitchel A. Kling, Barry R. Rittberg, W. J. Burke, Mark Hyman Rapaport, John Zajecka, Andrew A. Nierenberg, Mustafa M. Husain, David Ginsberg, R.G. Cooke	18
15	Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trial 2005 ·Schizophrenia Research ·Del D. Miller, Joseph P. McEvoy, Sonia M. Davis, Stanley N. Caroff, Bruce L. Saltz, Miranda Chakos, Marvin S. Swartz, Richard S.E. Keefe, Robert A. Rosenheck, T. Scott Stroup, Jeffrey A. Lieberman	123
16	Effects of 12 Months of Vagus Nerve Stimulation in Treatment-Resistant Depression: A Naturalistic Study 2005 ·Biological Psychiatry ·A. John Rush, Harold A. Sackeïm, Lauren B. Marangell, Mark S. George, Stephen K. Brannan, Sonia M. Davis, Phil Lavori, Robert H. Howland, Mitchel A. Kling, Barry R. Rittberg, Linda L. Carpenter, Philip T. Ninan, Francisco Moreno, Sonia Thomas, Charles R. Conway, Michael J. Burke, John J. Barry	270
17	Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia breakdown → 2005 ·New England Journal of Medicine ·Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy, Marvin S. Swartz, Robert A. Rosenheck, Diana O. Perkins, Richard S.E. Keefe, Sonia M. Davis, C.E. Davis, Barry D. Lebowitz, Joanne B. Severe, John Hsiao	4245
18	Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): Validity of the distinction. 2000 ·Journal of Abnormal Psychology ·(unknown), Daniel N. Klein, Martin B. Keller, Charles E. Holzer, Sonia M. Davis, Susan G. Kornstein, Robert H. Howland, Michael E. Thase, Wilma Harrison	49
19	Measuring the Diffusion of Innovative Health Promotion Programs 1992 ·American Journal of Health Promotion ·Allan Steckler, Robert M. Goodman, Kenneth R. McLeroy, Sonia M. Davis, Gary G. Koch	156
20	Core, secondary, and peripheral foods in the diets of Hispanic, Navajo, and Jemez Indian children. 1989 ·PubMed ·Kathleen M. Koehler, Mary B. Harris, Sonia M. Davis	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact